18-Mar-2010
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
About
|
Faculty Member List
|
Associate FMs
|
F1000 Reports
Search
All F1000
Pharmacology & D...
Gastrointestinal...
Browse
ALL OF BIOLOGY
Pharmacology & Drug Discovery
Antimicrobial Agents
Cancer Therapeutics
Cardiovascular Pharmacology
Drug Discovery & Design
Endocrine & Metabolic Pharmacology
Gastrointestinal Pharmacology
Genito-Urinary & Reproductive Pharmacology
Immunopharmacology & Hematologic Pharmacology
Molecular Pharmacology
Musculoskeletal & Dermatologic Pharmacology
Neuropharmacology & Psychopharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Renal Pharmacology
Respiratory Pharmacology
Toxicology
Related Sections
Bioinformatics
Biomacromolecule-Ligand Interactions
Cell Signalling
Cell Signalling & Trafficking Structures
Chemical Biology of the Cell
Directed Molecular Evolution
Genomics
Macromolecular Chemistry
Medical Genetics
Physiogenomics
Protein Chemistry & Proteomics
Small Molecule Chemistry
selected for
My F1000
Browse > Pharmacology & Drug Discovery > Gastrointestinal Pharmacology
Top 10
/
All time Top 10
/
Most viewed
/
Hidden jewels
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
confirmations
controversial
dissenting
drug target
hypotheses
new findings
refutation
tech advances
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
Novel Drug Target
S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.
Lu SC, Ramani K, …, Moats R, Grant E
Hepatology
2009 Aug
50
(2):462-71 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Henry Lin
Evaluated 26 Feb 2010
Must Read
F1000 Factor
6.0
New Finding
Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis.
Ko SB, Mizuno N, …, Muallem S, Goto H
Gastroenterology
2010 Jan 14 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Hwei Ling Ong and Indu Ambudkar
Evaluated 25 Feb 2010
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.
Yadav VK, Balaji S, …, Karsenty G, Ducy P
Nat Med
2010 Feb 7 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Gabriel R Linares and Subburaman Mohan
Evaluated 23 Feb 2010
Recommended
F1000 Factor
3.0
New Finding
Effect of human rotavirus vaccine on severe diarrhea in African infants.
Madhi SA, Cunliffe NA, …, Han HH, Neuzil KM
N Engl J Med
2010 Jan 28
362
(4):289-98 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Michael McChesney
Evaluated 16 Feb 2010
Recommended
F1000 Factor
3.0
Hypothesis
Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
Kovacevic I, Parojcic J, …, Tubic-Grozdanis M, Langguth P
Mol Pharm
2009 Jan-Feb
6
(1):40-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Isabel Gonzalez Alvarez and Marival Bermejo
Evaluated 3 Feb 2010
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
Controversial
Host range and cellular tropism of the human exogenous gammaretrovirus XMRV.
Stieler K, Schulz C, …, Stocking C, Fischer N
Virology
2010 Jan 26 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| David Alpers
Evaluated 3 Feb 2010
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli.
Brierley SM, Hughes PA, …, Rychkov GY, Blackshaw LA
Gastroenterology
2009 Dec
137
(6):2084-2095.e3 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Felix Viana
Evaluated 3 Feb 2010
Recommended
F1000 Factor
3.0
New Finding
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events.
Lammert C, Bjornsson E, Niklasson A, Chalasani N
Hepatology
2009 Sep 14 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Nicholas Meanwell
Evaluated 20 Jan 2010
Must Read
F1000 Factor
6.0
Tech Advance
Generation of functional human hepatic endoderm from human induced pluripotent stem cells.
Sullivan GJ, Hay DC, …, Iredale JP, Wilmut I
Hepatology
2010 Jan
51
(1):329-35 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Bruno Stieger
Evaluated 19 Jan 2010
Must Read
F1000 Factor
6.0
Confirmation
Hypothesis
New Finding
Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.
Williams DL, Baskin DG, Schwartz MW
Endocrinology
2009 Apr
150
(4):1680-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Andreas Stengel and Yvette Taché
Evaluated 12 Jan 2010
top of page
Page 1 of 6. Select Page:
1
2
3
4
5
6
>>
Display
10
/
20
/
50
papers per page
© 1999-2010 Faculty of 1000 Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info